Treating Lipid Abnormalities Beyond LDL - Washington Hospital ...
Treating Lipid Abnormalities Beyond LDL - Washington Hospital ...
Treating Lipid Abnormalities Beyond LDL - Washington Hospital ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
• 30,000 patients with occlusive arterial disease<br />
in North America, Europe and Asia<br />
• Background <strong>LDL</strong>-lowering with atorvastatin<br />
• Randomized to anacetrapib 100 mg vs. placebo<br />
• Scheduled follow-up: 4 years<br />
• Primary outcome: Coronary death, myocardial<br />
infarction or coronary revascularization<br />
www.revealtrial.org